Comparing Model Structures in Cost-Effectiveness Analysis

Abstract

Get full access to this article

View all access options for this article.

References

Drummond MF , Barbieri M , Wong JB . Analytic choices in economic models of treatments for rheumatoid arthritis: what makes a difference? Med Decis Making. 2005;25:520–533.

Weinstein MC , O’Brien B , Hornberger J , et al. Principles of good practice for decision analystic modeling in health-care evaluation; report of the ISPOR Task Force on Good Research Practices—modeling studies. Value Health. 2003;6(1):9–17.

Hawkins N , Sculpher M , Epstein D . Cost-effectiveness analysis of treatments for chronic disease—using R to incorporate time-dependency of treatment response. Med Decis Making. 2005;25: 511–519.

Pignone M , Russell L , Wagner J , eds. Economic Models of Colorectal Cancer Screening in Average-Risk Adults: Workshop Summary. Washington (DC): National Academies Press; 2005. Online access: http://www.iom.edu/report.asp?id=25197.

Hawkins N , Epstein D , Drummond M , et al. Assessing the cost-effectiveness of new pharmaceuticals in epilepsy in adults: the results of a probabilistic decision model. Med Decis Making. 2005;25:493–510.